GE Healthcare Obtains FDA Clearance for CT System GE Healthcare has received U.S. Food and Drug A

GE Healthcare Obtains FDA Clearance for CT System

GE Healthcare has received U.S. Food and Drug Administration (FDA) clearance for the Optima CT660, a compact computed tomography (CT) system.

“This next-generation CT system delivers on one of health care’s key challenges—generating precise clinical images and providing dose optimizing capabilities,” said Steve Gray, vice president and general manager of CT & Advantage Workstation for GE Healthcare. “Boosted by GE’s advanced low dose imaging technology, Optima CT660’s design and workflow enhancements also provide flexibility to facilities that may be constrained by space or resources—which aids healthcare professionals seeking to do more with less and best serve their patients’ needs.”

The Optima CT660 is the first CT system that is both ecomagination and healthymagination-certified, upholding two of GE’s global initiatives aimed at transforming healthcare delivery through innovation, partnerships and sustainability.

The system is scalable from 32 to 128 slices through various options and enables fast, high-performance imaging for patients at low doses. The system can be used in various clinical settings, including cardiac, neurological, emergency room and routine CT. The company claims the Optima CT660 will help healthcare professionals deliver personalized patient care through a combination of its dose-optimizing ASiR (Adaptive Statistical Iterative Reconstruction) technology, improved workflow features, and advanced applications for cardiovascular, oncology, neurology, CT angiography and other fields.